Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.46 |
| ▸ | RELA | Q04206 | 4/20 | 0.45 |
| ▸ | CASP2 | P42575 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | RRM1 | P23921 | 1/20 | 0.40 |
| ▸ | KDM4A | O75164 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.40 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27817058 | 1.00 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL28817375 | 0.99 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL31095863 | 0.88 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL1037232 | 0.88 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL3394523 | 0.88 | SLC6A5 (0.47) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL27971595 | 0.86 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL28264890 | 0.86 | SLC6A5 (0.46) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL3820683 | 0.86 | SLC6A5 (0.49) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL30997315 | 0.85 | SLC6A5 (0.50) | SLC6A5RELACASP2NAAAPAOX | |
| SCHEMBL28347983 | 0.85 | SLC6A5 (0.50) | SLC6A5RELACASP2NAAAPAOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110214005-A | Structures and methods for gene therapy | DNALite治疗学公司 | 2019-09-06 | — | — | CN | claimed |
| CN-101903018-B | LDL-like cationic nanoparticles for delivering nucleic acid genes, method for preparing same, and method for delivering nucleic acid genes using same | KOREA INST SCI & TECH | 2012-09-05 | — | — | CN | claimed |
| CN-102123733-A | Compositions comprising complex and naked RNAs for providing or enhancing an immunostimulatory response in a mammal and uses thereof | CUREVAC GMBH | 2011-07-13 | — | — | CN | claimed |
| CN-101903018-A | LDL-like cationic nanoparticles for delivering nucleic acid genes, method for preparing same, and method for delivering nucleic acid genes using same | KOREA ADVANCED INST SCI & TECH | 2010-12-01 | — | — | CN | claimed |
| CN-101041079-A | Novel colloid synthetic vectors for gene therapy | NOVARTIS AG (CH) | 2007-09-26 | — | — | CN | claimed |
| CN-110214005-A | Structures and methods for gene therapy | DNALite治疗学公司 | 2019-09-06 | — | — | CN | disclosed |
| CN-110179995-A | The targeting conjugate and its preparation of encapsulating in the grain | 塔弗达治疗有限公司 | 2019-08-30 | — | — | CN | disclosed |
| CN-104936622-B | Targeted conjugates encapsulated in particles and formulations thereof | 塔弗达治疗有限公司 | 2019-05-28 | — | — | CN | disclosed |
| CN-109045294-A | Influenza virus immunization Immunogenic Compositions and its application | 思齐乐 | 2018-12-21 | — | — | CN | disclosed |
| CN-108929880-A | Artificial nucleic acid molecules comprising a 5' TOPUTR | 库瑞瓦格股份公司 | 2018-12-04 | — | — | CN | disclosed |
| CN-104321432-B | Artificial nucleic acid molecules comprising a 5' TOP UTR | 库瑞瓦格股份公司 | 2018-08-10 | — | — | CN | disclosed |
| CN-104284979-B | The artificial nucleic acid molecule expressed for the albumen or peptide of raising | 库瑞瓦格股份公司 | 2018-06-08 | — | — | CN | disclosed |
| CN-101687032-A | Antagonist antibodies against ephb3 | NOVARTIS AG | 2010-03-31 | — | — | CN | disclosed |
| CN-101605530-A | Pharmaceutical preparation and process for its preparation | AMYLIN PHARMACEUTICALS INC (US) | 2009-12-16 | — | — | CN | disclosed |
| CN-101600344-A | Pesticidal aggregates | INNOVAFORM TECHNOLOGIES LLC (US) | 2009-12-09 | — | — | CN | disclosed |
| CN-101052383-A | Compositions and their uses for lysosomal enzyme deficiencies | UNIV MASSACHUSETTS (US) | 2007-10-10 | — | — | CN | disclosed |
| CN-101041079-A | Novel colloid synthetic vectors for gene therapy | NOVARTIS AG (CH) | 2007-09-26 | — | — | CN | disclosed |
| CN-1988919-A | Liposome-containing radiographic contrast medium and preparation method thereof | KONICA MINOLTA MED & GRAPHIC (JP) | 2007-06-27 | — | — | CN | disclosed |
| CN-1433478-A | Colloidal synthetic vector for gene therapy | NOVARTIS AG (CH) | 2003-07-30 | — | — | CN | disclosed |
| CN-1177291-A | Stable lipid-containing drug delivery complexes and methods for their production | UNIV PITTSBURGH (US) | 1998-03-25 | — | — | CN | disclosed |